Real-time enrollment status for this hypertension clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:37 AM UTC
| NCT Number | NCT07090161 |
| Recruiting Status | Recruiting |
| Condition | Hypertension |
| Phase | Clinical Trial |
| Target Enrollment | 240 participants |
| Active Locations | 28 sites in the US |
| Sponsor | Vanda Pharmaceuticals |
| Last Updated on CT.gov | February 27, 2026 (Feb 27, 2026) |
As of July 13, 2026: Clinical trial NCT07090161 is currently recruiting participants. This clinical trial study for hypertension is actively seeking new participants at 28 locations across the United States. The study is sponsored by Vanda Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07090161 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 28 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07090161 was last updated Feb 27, 2026 (February 27, 2026). HelloStudys verifies this status automatically.